Absci Corp
ABSI2.985USD
+0.085+2.93%
交易中 （美东）报价延迟15分钟
380.71M总市值
亏损市盈率 TTM
关于 Absci Corp 公司
Absci Corporation 是一家数据优先的生成人工智能 (AI) 药物创造公司。该公司将 AI 与可扩展的湿实验室技术相结合，为患者创造生物制剂。该公司的综合药物创造平台通过同时优化对开发和治疗效益都很重要多种药物特性，释放了加快临床时间和提高成功概率的潜力。通过训练数据、创造 AI 和验证湿实验室，其综合药物创造平台旨在设计生物制剂。该公司正在开发一个多元化的项目组合，重点是细胞因子生物学。它有三个专注于细胞因子生物学的全资内部管线项目，以及几个正在评估的其他未公开的管线项目。其全资管线项目包括 ABS-101、ABS-201 和 ABS-301。该公司的其他管线项目包括 ABS-501 和其他药物创造项目。
公司简介
公司代码ABSI
公司名称Absci Corp
上市日期Jul 22, 2021
CEOMr. Sean Mcclain
员工数量156
证券类型Ordinary Share
年结日Jul 22
公司地址18105 Se Mill Plain Blvd
城市VANCOUVER
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编98683
电话13609491041
网址https://www.absci.com/
公司代码ABSI
上市日期Jul 22, 2021
CEOMr. Sean Mcclain
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Sean Mcclain
Mr. Sean Mcclain
Chief Executive Officer, Founder, Director
Chief Executive Officer, Founder, Director
8.73M
+1.38%
Dr. Zachariah (Zach) Jonasson, Ph.D.
Dr. Zachariah (Zach) Jonasson, Ph.D.
Chief Financial Officer, Chief Business Officer
Chief Financial Officer, Chief Business Officer
133.62K
-3.74%
Mr. Andreas Busch, Ph.D.
Mr. Andreas Busch, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
131.48K
+61.36%
Ms. Shelby J. Walker, J.D.
Ms. Shelby J. Walker, J.D.
Chief Legal Officer
Chief Legal Officer
59.30K
--
Ms. Karen K. Mcginnis, CPA
Ms. Karen K. Mcginnis, CPA
Independent Director
Independent Director
29.50K
+96.67%
Mr. Daniel A. (Dan) Rabinovitsj
Mr. Daniel A. (Dan) Rabinovitsj
Independent Director
Independent Director
14.50K
--
Ms. Mary T. Szela
Ms. Mary T. Szela
Director
Director
--
--
Mr. Frans Van Houten
Mr. Frans Van Houten
Independent Chairman of the Board
Independent Chairman of the Board
--
-100.00%
Prof. Dr. Menelas (Mene) Pangalos, Ph.D.
Prof. Dr. Menelas (Mene) Pangalos, Ph.D.
Independent Director
Independent Director
--
--
Dr. Joseph Sirosh, Ph.D.
Dr. Joseph Sirosh, Ph.D.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Sean Mcclain
Mr. Sean Mcclain
Chief Executive Officer, Founder, Director
Chief Executive Officer, Founder, Director
8.73M
+1.38%
Dr. Zachariah (Zach) Jonasson, Ph.D.
Dr. Zachariah (Zach) Jonasson, Ph.D.
Chief Financial Officer, Chief Business Officer
Chief Financial Officer, Chief Business Officer
133.62K
-3.74%
Mr. Andreas Busch, Ph.D.
Mr. Andreas Busch, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
131.48K
+61.36%
Ms. Shelby J. Walker, J.D.
Ms. Shelby J. Walker, J.D.
Chief Legal Officer
Chief Legal Officer
59.30K
--
Ms. Karen K. Mcginnis, CPA
Ms. Karen K. Mcginnis, CPA
Independent Director
Independent Director
29.50K
+96.67%
Mr. Daniel A. (Dan) Rabinovitsj
Mr. Daniel A. (Dan) Rabinovitsj
Independent Director
Independent Director
14.50K
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 6月24日 周二
更新时间: 6月24日 周二
持股股东
股东类型
持股股东
持股股东
占比
Fidelity Management & Research Company LLC
12.75%
ARK Investment Management LLC
6.97%
McClain (Sean)
6.05%
Redmile Group, LLC
5.72%
The Vanguard Group, Inc.
4.47%
Other
64.04%
持股股东
持股股东
占比
Fidelity Management & Research Company LLC
12.75%
ARK Investment Management LLC
6.97%
McClain (Sean)
6.05%
Redmile Group, LLC
5.72%
The Vanguard Group, Inc.
4.47%
Other
64.04%
股东类型
持股股东
占比
Investment Advisor
36.08%
Investment Advisor/Hedge Fund
18.18%
Individual Investor
6.46%
Hedge Fund
4.02%
Corporation
3.29%
Research Firm
1.79%
Bank and Trust
0.24%
Venture Capital
0.21%
Pension Fund
0.02%
Other
29.72%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
307
100.37M
69.60%
-3.07M
2025Q1
316
100.15M
78.58%
-546.74K
2024Q4
298
92.04M
80.13%
-8.74M
2024Q3
280
90.06M
79.27%
-8.98M
2024Q2
257
91.26M
83.61%
+4.72M
2024Q1
236
84.09M
77.41%
+14.50M
2023Q4
202
58.01M
62.41%
-6.63M
2023Q3
196
57.87M
62.40%
-7.67M
2023Q2
191
58.28M
63.02%
-12.48M
2023Q1
181
65.82M
71.20%
-6.10M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Fidelity Management & Research Company LLC
18.39M
14.41%
+4.87M
+36.07%
Mar 31, 2025
ARK Investment Management LLC
10.96M
8.59%
+2.69M
+32.53%
Mar 31, 2025
McClain (Sean)
8.73M
6.84%
+119.00K
+1.38%
Mar 31, 2025
Redmile Group, LLC
8.25M
6.47%
--
--
Apr 25, 2025
The Vanguard Group, Inc.
4.69M
3.67%
-86.40K
-1.81%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
6.25M
4.9%
+325.67K
+5.50%
Mar 31, 2025
Phoenix Ventures Partners II LP.
4.75M
3.72%
-4.61M
-49.28%
Mar 31, 2025
Fred Alger Management, LLC
4.29M
3.37%
-2.21M
-33.99%
Mar 31, 2025
Columbia Wanger Asset Management, LLC
2.40M
1.88%
--
--
Mar 31, 2025
MFS Investment Management
2.31M
1.81%
+20.59K
+0.90%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
ARK Genomic Revolution ETF
2.39%
WisdomTree BioRevolution Fund
0.95%
iShares Micro-Cap ETF
0.06%
Invesco Nasdaq Biotechnology ETF
0.04%
ProShares Ultra Nasdaq Biotechnology
0.04%
iShares Biotechnology ETF
0.03%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
查看更多
ARK Genomic Revolution ETF
占比2.39%
WisdomTree BioRevolution Fund
占比0.95%
iShares Micro-Cap ETF
占比0.06%
Invesco Nasdaq Biotechnology ETF
占比0.04%
ProShares Ultra Nasdaq Biotechnology
占比0.04%
iShares Biotechnology ETF
占比0.03%
Proshares Ultra Russell 2000
占比0.01%
ProShares UltraPro Russell2000
占比0.01%
iShares Russell 2000 Growth ETF
占比0.01%
Schwab U.S. Small-Cap ETF
占比0.01%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
